JASON BAYARD: Open Payments
NPI 1184034886 · LOREAUVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 110 payments from 16 companies in 2025. Trend: 2023 $829 · 2024 $1,234 · 2025 $2,371
Food & beverage: $2,354Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $588 |
| AstraZeneca Pharmaceuticals LP | 22 | $440 |
| Regeneron Healthcare Solutions, Inc. | 16 | $376 |
| GENZYME CORPORATION | 10 | $252 |
| Verona Pharma, Inc. | 12 | $228 |
| Viatris Specialty LLC | 7 | $145 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| Insmed, Inc. | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| United Therapeutics Corporation | 1 | $33 |
Products named: DUPIXENT, TRELEGY ELLIPTA, FASENRA, Ohtuvayre, NUCALA, YUPELRI, TEZSPIRE, BREZTRI.
Industry payments across LA — which companies pay providers there.
